James McArthur currently serves as President and Chief Executive Officer of PepGen and serves on the company’s Board of Directors. James has 25+ years of industry experience, has cofounded five biotechnology companies, three of which were acquired, and has served as a director of two companies through successful initial public offerings. James has served in several leadership positions of increasing responsibility at major rare disease and gene and stem cell therapy companies. Prior to these companies, he was a Venture Partner at RA Capital and an entrepreneur in residence at HealthCare Ventures. James was previously a post-doctoral fellow at MIT and UC Berkeley, working with Drs. David Raulet and Nobel Laureate James Allison, before which he received his Ph.D. in molecular oncology and BSc in biochemistry from McGill University in Montreal.